Manage Your Liver
Q:

What can be done to protect your liver if you cannot afford costly antiviral Hepatitis C treatment?

What can be done to protect your liver if you cannot afford costly antiviral Hepatitis C treatment?
A:

Eliminating the virus in patients’ body has been deemed as the only approach to treat hepatitis C. Direct-acting antiviral drugs (DDAs) launched in recent years are proved to be more effective than interferon, but they are very expensive, thus arousing great debate in the society. Take the latest DAA as example, the cost of a twelve-week treatment is $94,500, that means a single pill costs $1125. Patients with cirrhosis who have failed prior treatment require 24 weeks of DAA treatment [1], this amount is unaffordable to the majority of the public. With other obstacles such as side effects and low effectiveness, are there other options for hepatitis C patients?

 

Although liver damage in Hepatitis C patients is caused by the hepatitis virus, Dr. Howard Monsour, M.D. suggested that “it is more important 'how' your body responds to the presence of the hepatitis C virus in your liver than 'how much' virus is in your liver that counts." [2] The amount of virus in the body actually does not directly relate to the extent of liver damage. Therefore, patients should focus primarily on the health of liver cells (which can be reflected by the ALT level).

 

To the liver, the biggest threat is not the virus, but the chronic inflammation caused by attacks on the liver cells. In fact, some patients’ have normal liver function and health despite a high viral count [3]. This proves that presence of virus in the body does not necessarily bring inflammation. Therefore, antiviral treatment is not the only treatment option for hepatitis C. Patients who are not able to receive treatment should understand that it is possible to live with the virus; the key is to enhance protection of the liver and stop inflammation.

 

In view of this, patients’ top priority should be to stop inflammation and antiviral treatment is not the only approach. A large number of scientific studies and clinical reports have proven that there are treatment options other than DAAs that can reduce liver inflammation, repair liver cells and normalize ALT level which are also highly effective and gentler on the body. [4][5]


Undoubtedly, successful eradication of the virus is the most ideal to patients; however the sacrifices and risks are not affordable to everyone. Patients must understand that the main objective of treatment is to regain liver health and this can only be achieved when inflammation is stopped.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Hepatitis CHepatitis C treatmentcostly antiviral treatmentDAAs
Related Questions
A:
In our last post, we brought up the recent findings on extreme liver cancer growth after successful DAA treatment. We are talking about liver cancer of a few centimetres developed within weeks of successful Hep C treatment. These findings are also observed in patients of Gastroenterology. Dr. Roushdi Khalf allah sai
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us